ロード中...
Safety and tolerability of nevirapine-based antiretroviral therapy in HIV-infected patients receiving fluconazole for cryptococcal prophylaxis: a retrospective cohort study
BACKGROUND: To compare the adverse events after initiation of nevirapine-based ART among HIV-infected patients who did not receive fluconazole (group A), received fluconazole 400 mg/week (group B), and received fluconazole 200 mg/day (group C). METHODS: A retrospective cohort study was conducted amo...
保存先:
| 主要な著者: | , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2005
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1199598/ https://ncbi.nlm.nih.gov/pubmed/16120209 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2334-5-67 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|